Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

NCT03660800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitamin D Insufficiency
Secondary Hyperparathyroidism

Interventions

DRUG: CTAP101 Capsules

Sponsor

OPKO Health, Inc.